InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Oler Abraham N., Vice-Président et Conseiller Général. Officer active across 1 company, notably Onconova Therapeutics, Inc.. Cumulatively, 7 disclosures have been logged. Breakdown: 6 buys · 0 sell. Total volume traded: €22k. Activity tracked since 28 September 2021. The latest transaction was filed on 28 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Oler Abraham N.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
1,500 shares@ US$1.676.3% of flowCommon StockSEC:0001179110-22-000652:0
Canonical exit: 28 Apr 2022 (T+90)
1,500 shares@ US$2.027.5% of flowCommon StockSEC:0001179110-22-000564:0
Canonical exit: 21 Apr 2022 (T+90)
1,500 shares@ US$2.208.1% of flowCommon StockSEC:0001415889-22-000588:0
Canonical exit: 14 Apr 2022 (T+90)
1,500 shares@ US$2.398.9% of flowCommon StockSEC:0001179110-22-000350:0
Canonical exit: 7 Apr 2022 (T+90)
1,000 shares@ US$3.167.8% of flowCommon stockSEC:0001415889-21-005425:0
Canonical exit: 17 Feb 2022 (T+90)
5,000 shares@ US$3.0037.3% of flowCommon StockSEC:0001179110-21-010259:0
2,381 shares@ US$4.2024.1% of flowCommon StockSEC:0001179110-21-008982:0
Canonical exit: 27 Dec 2021 (T+90)
7 of 7 declarations
About Oler Abraham N.
OLER ABRAHAM N. is Vice-Président et Conseiller Général. He is linked to Onconova Therapeutics, Inc. as SVP Corp Dev & Gen Counsel. The declarant has 7 filings in total, and across the 7 recent filings observed between 2021-09-29 and 2022-01-31, buy volume is EUR 22316 and sell volume is EUR 0, with the dominant transaction nature indicated as Acquisition.
